Net profit of Sun Pharmaceuticals Industries rose 15.04% to Rs 2903.38 crore in the quarter ended December 2024 as against Rs 2523.75 crore during the previous quarter ended December 2023. Sales rose 10.53% to Rs 13436.94 crore in the quarter ended December 2024 as against Rs 12156.86 crore during the previous quarter ended December 2023.
| Particulars | Quarter Ended | ||
| Dec. 2024 | Dec. 2023 | % Var. | |
| Sales | 13436.94 | 12156.86 | 11 |
| OPM % | 29.84 | 28.60 | - |
| PBDT | 4423.13 | 3692.30 | 20 |
| PBT | 3792.57 | 3070.16 | 24 |
| NP | 2903.38 | 2523.75 | 15 |
Powered by Capital Market - Live News